Tres Alchemix, an AI biotech startup, has raised $4.4M in Series A funding to expand its predictive drug-design platform. With a new lab opening in Oxford, UK, the company aims to accelerate AI-driven ...
Scientists at Université de Montreal and its Institute for Research in Immunology and Cancer have begun a phase-1 clinical ...
Hosted on MSN
Chemistry LLM developed for faster drug discovery
Southwest Research Institute scientists and engineers have developed a custom large language model (LLM) to accelerate drug design and discovery. Subscribe to our newsletter for the latest sci-tech ...
Imagine a future where your doctor could prescribe drugs that meet your needs even before symptoms show up. This dream is ...
Deep EigenMatics, a startup developing innovative Artificial Intelligence methods for drug discovery and development, has ...
Artificial intelligence has already made its mark in commercial industries, and there's a good argument to be made that AI is most impactful in the drug discovery marketplace: Drug discovery companies ...
TOKYO--(BUSINESS WIRE)--Elix, Inc. (CEO: Shinya Yuki / Headquarters: Tokyo; hereinafter “Elix”) is pleased to announce that its AI drug discovery platform, Elix ...
Computational drug discovery and design embodies the integration of advanced computational methods, machine learning, and cheminformatics to streamline the identification and optimisation of ...
AUSTIN, Texas and VANCOUVER, Washington, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Absci (ABSI), a clinical-stage biotech company advancing novel therapeutics with generative AI, today announced a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback